bioRxivBiochemistryPreprint
Conformational dynamics of the μ-opioid receptor determine ligand intrinsic efficacy
J. Zhao, M. Elgeti, E. O'Brien, C. Sar, A. El Daibani, J. Heng, X. Sun, T. Che, W. L. Hubbell, B. Kobilka, C. Chen
Abstract
The -opioid receptor (OR) is an important target for pain management and the molecular understanding of drug action will facilitate the development of better therapeutics. Here we show, using double electron-electron resonance (DEER) and single-molecule fluorescence resonance energy transfer (smFRET), how ligand-specific conformational changes of the OR translate into a broad range of intrinsic efficacies at the transducer level. We identify several cytoplasmic receptor conformations interconverting on different timescales, including a pre-activated receptor conformation which is capable of G protein binding, and a fully activated conformation which dramatically lowers GDP affinity within the ternary complex. Interaction of {beta}-arrestin-1 with the OR core binding site appears less specific and occurs with much lower affinity than binding of G protein Gi. One-Sentence SummaryLigand-dependent conformational dynamics of the -opioid receptor determine downstream signaling efficacy.
- research focus: protein folding & dynamics
- research focus: host-pathogen & immune response
- approach: experimental assay
- approach: biophysical modeling
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Ligand-dependent G protein dynamics underlying opioid signaling efficacy
Jonathan C. Deutsch, Daniel Hilger, … Rabindra V. Shivnaraine·bioRxiv·Jun 30, 2025
- Molecular insights into the μ-opioid receptorselective signaling
Xiaojing Cong, Damien Maurel, … Rémy Sounier·bioRxiv·Mar 22, 2021
- Intracellular pocket conformations determine signaling through the μ opioid receptor
D. A. Cooper, J. DePaolo-Boisvert, … D. Minh·bioRxiv·Apr 3, 2024
- Distinct activation mechanisms underlie ligand efficacy at a GPCR
Marybeth Howard, Eve J. Fine, … Willow Coyote‐Maestas·bioRxiv·Oct 18, 2026
- Buprenorphine Restricts the Conformational Landscape of the μ-Opioid Receptor
Simone Aureli, Maria Bzówka, … Francesco Luigi Gervasio·bioRxiv·Jun 16, 2026
- Non-Equilibrium Snapshots of Ligand Efficacy at the μ-Opioid Receptor
Michael J. Robertson, Arnab Modak, … Georgios Skiniotis·NaturePeer-reviewed·Dec 22, 2025